Cargando…
The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768824/ https://www.ncbi.nlm.nih.gov/pubmed/33381032 http://dx.doi.org/10.3389/fphar.2020.578396 |
_version_ | 1783629216422559744 |
---|---|
author | Operto, Francesca Felicia Matricardi, Sara Pastorino, Grazia Maria Giovanna Verrotti, Alberto Coppola, Giangennaro |
author_facet | Operto, Francesca Felicia Matricardi, Sara Pastorino, Grazia Maria Giovanna Verrotti, Alberto Coppola, Giangennaro |
author_sort | Operto, Francesca Felicia |
collection | PubMed |
description | The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studies in mood and neurodevelopmental disorders such as anxiety, depression and autism spectrum disorders. Mood disorders in comorbidity with epilepsy are commonly seen in adolescents and young adults both at the onset and during the course of the epileptic disorder. The rationale for the use of the ketogenic diet is based on the potential mood stabilizing effects through level modifications of metabolites such as dopamine and serotonin and the regulation of GABA/glutamatergic neurotransmission, mitochondrial function and oxidative stress. In this review, epilepsies with a higher risk of mood disorders in adolescents will be considered. A brief overview of the various types of ketogenic diet that can currently be offered to young patients in order to improve palatability and compliance with the diet, is also included. The efficacy and tolerability of the ketogenic diet options for the treatment of mood disorders, with or without drug therapy including mood stabilizers and antidepressant drugs, are as well discussed. |
format | Online Article Text |
id | pubmed-7768824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77688242020-12-29 The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents Operto, Francesca Felicia Matricardi, Sara Pastorino, Grazia Maria Giovanna Verrotti, Alberto Coppola, Giangennaro Front Pharmacol Pharmacology The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studies in mood and neurodevelopmental disorders such as anxiety, depression and autism spectrum disorders. Mood disorders in comorbidity with epilepsy are commonly seen in adolescents and young adults both at the onset and during the course of the epileptic disorder. The rationale for the use of the ketogenic diet is based on the potential mood stabilizing effects through level modifications of metabolites such as dopamine and serotonin and the regulation of GABA/glutamatergic neurotransmission, mitochondrial function and oxidative stress. In this review, epilepsies with a higher risk of mood disorders in adolescents will be considered. A brief overview of the various types of ketogenic diet that can currently be offered to young patients in order to improve palatability and compliance with the diet, is also included. The efficacy and tolerability of the ketogenic diet options for the treatment of mood disorders, with or without drug therapy including mood stabilizers and antidepressant drugs, are as well discussed. Frontiers Media S.A. 2020-11-24 /pmc/articles/PMC7768824/ /pubmed/33381032 http://dx.doi.org/10.3389/fphar.2020.578396 Text en Copyright © 2020 Operto, Matricardi, Pastorino, Verrotti and Coppola http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Operto, Francesca Felicia Matricardi, Sara Pastorino, Grazia Maria Giovanna Verrotti, Alberto Coppola, Giangennaro The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title | The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title_full | The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title_fullStr | The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title_full_unstemmed | The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title_short | The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents |
title_sort | ketogenic diet for the treatment of mood disorders in comorbidity with epilepsy in children and adolescents |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768824/ https://www.ncbi.nlm.nih.gov/pubmed/33381032 http://dx.doi.org/10.3389/fphar.2020.578396 |
work_keys_str_mv | AT opertofrancescafelicia theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT matricardisara theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT pastorinograziamariagiovanna theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT verrottialberto theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT coppolagiangennaro theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT opertofrancescafelicia ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT matricardisara ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT pastorinograziamariagiovanna ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT verrottialberto ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents AT coppolagiangennaro ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents |